Naciepi Vial 50mg with 1 Ampoule (Epirubicin)

Category

Antineoplastics

Line

Oncology

Brand

Naciepi

Molecule

Epirubicin

Presentation

Vial with 1 ampule of 50 mg

Laboratory

Novag

Indications

Naciepi is indicated for the treatment of various types of cancer, including breast cancer, lung cancer, and other solid tumors. Epirubicin works by interfering with DNA replication in malignant cells, which helps reduce their growth and proliferation. This medication is used as part of a chemotherapy regimen and can be administered alone or in combination with other chemotherapeutic agents. It is important that the administration of Naciepi be supervised by a physician specializing in oncology, who will determine the appropriate dose and treatment regimen for each patient, based on the type and stage of cancer, as well as the patient's general health.

Composition

Each ampule of Naciepi contains 50 mg of epirubicin, as well as excipients that facilitate its formulation and administration.

Contraindications

Naciepi is contraindicated in patients with known hypersensitivity to epirubicin or any of the formula's components. Furthermore, it should not be administered to patients with severe infections, significant heart failure, or those who have received previous treatments with high doses of anthracyclines.

Precautions

It is essential to perform cardiac function tests before and during treatment with Naciepi, as epirubicin can cause cardiac toxicity. Caution should be exercised in patients with renal or hepatic insufficiency, as well as in those receiving concomitant treatment with other medications that may affect cardiac function. Close monitoring of patients is recommended to detect any signs of adverse reactions.

Storage

Store Naciepi at room temperature, protected from light and moisture. Keep out of reach of children. Do not use after the expiration date indicated on the package.

Prescription required.

Consult your doctor.